215 related articles for article (PubMed ID: 23721853)
1. Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy.
Feldman-Stewart D; Madarnas Y; Mates M; Tong C; Grunfeld E; Verma S; Carolan H; Brundage M
Breast; 2013 Oct; 22(5):919-25. PubMed ID: 23721853
[TBL] [Abstract][Full Text] [Related]
2. Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy.
Feldman-Stewart D; Madarnas Y; Mates M; Tong C; Grunfeld E; Verma S; Carolan H; Brundage M
Patient Educ Couns; 2013 Oct; 93(1):114-21. PubMed ID: 23747087
[TBL] [Abstract][Full Text] [Related]
3. The information needed by Canadian early-stage prostate cancer patients for decision-making: stable over a decade.
Feldman-Stewart D; Brennenstuhl S; Brundage MD
Patient Educ Couns; 2008 Dec; 73(3):437-42. PubMed ID: 18762405
[TBL] [Abstract][Full Text] [Related]
4. A Patient-centered Approach to Evaluate the Information Needs of Women With Ductal Carcinoma In Situ.
Lo AC; Olson R; Feldman-Stewart D; Truong PT; Aquino-Parsons C; Bottorff JL; Carolan H
Am J Clin Oncol; 2017 Dec; 40(6):574-581. PubMed ID: 25730602
[TBL] [Abstract][Full Text] [Related]
5. Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer.
Sanft T; Aktas B; Schroeder B; Bossuyt V; DiGiovanna M; Abu-Khalaf M; Chung G; Silber A; Hofstatter E; Mougalian S; Epstein L; Hatzis C; Schnabel C; Pusztai L
Breast Cancer Res Treat; 2015 Dec; 154(3):533-41. PubMed ID: 26578401
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
7. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
8. Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomy.
Wong J; D'Alimonte L; Angus J; Paszat L; Metcalfe K; Whelan T; Llewellyn-Thomas H; Warner E; Franssen E; Szumacher E
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):30-8. PubMed ID: 22331002
[TBL] [Abstract][Full Text] [Related]
9. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595
[TBL] [Abstract][Full Text] [Related]
10. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
12. Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.
Levine MN; Julian JA; Bedard PL; Eisen A; Trudeau ME; Higgins B; Bordeleau L; Pritchard KI
J Clin Oncol; 2016 Apr; 34(10):1065-71. PubMed ID: 26598746
[TBL] [Abstract][Full Text] [Related]
13. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
14. Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis.
Bell RJ; Schwarz M; Fradkin P; Robinson PJ; Davis SR
Menopause; 2013 Jul; 20(7):721-6. PubMed ID: 23793165
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept.
Iwata H
Breast Cancer; 2011 Apr; 18(2):92-7. PubMed ID: 21140250
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy study of 5-year letrozole or anastrozole in postmenopausal hormone receptor-positive early breast cancer.
Sendur MA; Aksoy S; Zengin N; Altundag K
J BUON; 2013; 18(4):838-44. PubMed ID: 24344006
[TBL] [Abstract][Full Text] [Related]
17. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
[TBL] [Abstract][Full Text] [Related]
18. Understanding discontinuation of oral adjuvant endocrine therapy by women with hormone receptor-positive invasive breast cancer nearly 4 years from diagnosis.
Bell RJ; Fradkin P; Schwarz M; Davis SR
Menopause; 2013 Jan; 20(1):15-21. PubMed ID: 22948136
[TBL] [Abstract][Full Text] [Related]
19. Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Filipits M; Rudas M; Heinzl H; Jakesz R; Kubista E; Lax S; Schippinger W; Dietze O; Greil R; Stiglbauer W; Kwasny W; Nader A; Stierer M; Gnant MF;
Clin Cancer Res; 2009 Sep; 15(18):5888-94. PubMed ID: 19723645
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant endocrine therapy in postmenopausal breast cancer patients: does hormone receptor status influence decision-making?
Puglisi F; Minisini AM
Crit Rev Oncol Hematol; 2011 Feb; 77(2):87-99. PubMed ID: 20133149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
